Literature DB >> 7925463

Comparison of the inhibitory action of natural rotenone and its stereoisomers with various NADH-ubiquinone reductases.

H Ueno1, H Miyoshi, K Ebisui, H Iwamura.   

Abstract

Two stereoisomers of natural rotenone (5'alpha-epirotenone and 5'beta-epirotenone) were synthesized to identify the stereochemical factor of rotenone required for the inhibition and also to probe the structure of the rotenone binding site. The inhibitory action of the stereoisomers was compared with that of rotenone using NADH-ubiquinone reductases from bovine heart submitochondrial particles (SMP), potato tubers (Solanum tuberosum L.) SMP and Escherichia coli (GR19N) membranes. With respect to bovine heart SMP, it was found that the bent form of rotenone is essential for the activity. The modification of the E-ring moiety also affected both the inhibitory potency and the pattern of inhibition. These results indicated that the rotenone-binding site recognizes the whole molecular structure (or shape) of rotenone in a strict sense. Rotenone and 5'beta-epirotenone inhibited the NADH-ubiquinone reductase of bovine heart SMP in a noncompetitive manner against exogenous quinones. In contrast, the inhibition pattern of 5'alpha-epirotenone varied from noncompetitive to competitive as the concentration of quinone increased. These results suggest that rotenone binds close to, but not at a site identical to, the location for ubiquinone in the ubiquinone-catalytic reaction site, whereas the 5'alpha-epirotenone-binding site overlaps that for ubiquinone due to a structural modification of E-ring moiety. Furthermore, the complex inhibition pattern of 5'alpha-epirotenone suggests that there are two quinone-binding sites in NADH-ubiquinone reductase. In contrast, the order of the inhibitory potencies of the three inhibitors with proton-pumping NADH-ubiquinone reductase of potato SMP was the same as that observed for the bovine enzyme. This suggests that the structure of rotenone-binding sites (or ubiquinone-binding sites) of these enzymes are similar. It was further demonstrated that 5'alpha-epirotenone inhibits quinone binding to both proton-pumping and non-proton-pumping NADH-ubiquinone reductases of potato SMP in a competitive manner. With respect to the proton-pumping NADH-ubiquinone reductase of the E. coli membrane, the sensitivity of the enzyme to the inhibitor was remarkably decreased and the difference in the inhibitory potencies of the three inhibitors became ambiguous. In addition, the inhibition pattern of the three inhibitors was competitive against quinone. These results indicated that, contrary to the mammalian enzyme, only part of the rotenone molecule is recognized by the quinone-binding site of this enzyme.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925463     DOI: 10.1111/j.1432-1033.1994.00411.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  [3H]dihydrorotenone binding to NADH: ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study.

Authors:  D S Higgins; J T Greenamyre
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

Review 2.  Probing the ubiquinone reduction site in bovine mitochondrial complex I using a series of synthetic ubiquinones and inhibitors.

Authors:  H Miyoshi
Journal:  J Bioenerg Biomembr       Date:  2001-06       Impact factor: 2.945

3.  Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase.

Authors:  S Pitkanen; B H Robinson
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

4.  Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent.

Authors:  Padmaja Yalamanchili; Eric Wexler; Megan Hayes; Ming Yu; Jody Bozek; Mikhail Kagan; Heike S Radeke; Michael Azure; Ajay Purohit; David S Casebier; Simon P Robinson
Journal:  J Nucl Cardiol       Date:  2007-10-22       Impact factor: 5.952

5.  Hydroxylated Rotenoids Selectively Inhibit the Proliferation of Prostate Cancer Cells.

Authors:  David A Russell; Hannah R Bridges; Riccardo Serreli; Sarah L Kidd; Natalia Mateu; Thomas J Osberger; Hannah F Sore; Judy Hirst; David R Spring
Journal:  J Nat Prod       Date:  2020-05-27       Impact factor: 4.050

6.  Role of yqiC in the Pathogenicity of Salmonella and Innate Immune Responses of Human Intestinal Epithelium.

Authors:  Ke-Chuan Wang; Chih-Hung Huang; Shih-Min Ding; Ching-Kuo Chen; Hsu-Wei Fang; Ming-Te Huang; Shiuh-Bin Fang
Journal:  Front Microbiol       Date:  2016-10-10       Impact factor: 5.640

7.  Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials.

Authors:  Li Lei; Yan Liu
Journal:  BMC Cardiovasc Disord       Date:  2017-07-24       Impact factor: 2.298

Review 8.  The Mitochondrial Complex(I)ty of Cancer.

Authors:  Félix A Urra; Felipe Muñoz; Alenka Lovy; César Cárdenas
Journal:  Front Oncol       Date:  2017-06-08       Impact factor: 6.244

9.  Pseudomonas Quinolone Signal molecule PQS behaves like a B Class inhibitor at the IQ site of mitochondrial complex I.

Authors:  Bettina Rieger; Sven Thierbach; Miriam Ommer; Finja S V Dienhart; Susanne Fetzner; Karin B Busch
Journal:  FASEB Bioadv       Date:  2020-02-19

10.  Inhibitory Effects of Amorphigenin on the Mitochondrial Complex I of Culex pipiens pallens Coquillett (Diptera: Culicidae).

Authors:  Mingshan Ji; Yaping Liang; Zumin Gu; Xiuwei Li
Journal:  Int J Mol Sci       Date:  2015-08-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.